theophylline has been researched along with sulfacetamide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Bottari, F; di Colo, G; Nannipieri, E; Saettone, MF; Serafini, MF | 1 |
Barzó, P; Biró, B; Nagy, E | 1 |
4 other study(ies) available for theophylline and sulfacetamide
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Dynamic permeation. Note II - Evaluation of the interaction of pectin with some pharmaceuticals.
Topics: Aminosalicylic Acids; Animals; Binding Sites; Cattle; Cell Membrane Permeability; Drug Interactions; Pectins; Sulfacetamide; Sulfathiazoles; Theophylline | 1976 |
[New drug composition, used as a room aerosol].
Topics: Aerosols; Ascorbic Acid; Boric Acids; Drug Combinations; Humans; Isoproterenol; Lung Diseases, Obstructive; Propylene Glycols; Respiratory Function Tests; Respiratory Therapy; Sulfacetamide; Theophylline; Vital Capacity | 1972 |